Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kymera Therapeutics, Inc.

KYMR Clue Score27
United States Fiscal year ends December CIK 0001815442 Results filed 29 Oct 2026

What the insiders did Net selling

By person

23 insiders · 595 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Bruce Booth
Director
—
$314.97M (216) scheduled
−$314.97M
466,077
0.5605%
$54.12M
—
Baker Bros. Advisors LP entity
Director
$201.34M (5)
—
+$201.34M
7,955,916
9.57%
$923.84M
+50.3%
Bvf Partners L P/Il entity
Director
$84.80M (40)
$173.67M (4)
−$88.86M
318,910
0.3835%
$37.03M
—
Nello Mainolfi
Chief Executive Officer
—
$55.37M (78) scheduled
−$55.37M
666,568
0.8016%
$77.40M
+75.0%
Atlas Venture Fund X, L.P. entity
10% owner
—
$46.06M (40)
−$46.06M
5,504,905
6.62%
$639.23M
+631.6%
Atlas Venture Associates X, L.p. entity
10% owner
—
$27.73M (2)
−$27.73M
0
0.0000%
$0.00
−100.0%
Jared Gollob
Chief Medical Officer
—
$20.60M (46) scheduled
−$20.60M
117,134
0.1409%
$13.60M
+8.9%
Bruce N. Jacobs
Chief Financial Officer
—
$18.73M (41) scheduled
−$18.73M
244,883
0.2945%
$28.44M
+886.6%
Jeremy G Chadwick
Chief Operating Officer
—
$15.81M (33) scheduled
−$15.81M
44,018
0.0529%
$5.11M
+2,137%
Richard Chesworth
Chief Scientific Officer
—
$4.75M (5) scheduled
−$4.75M
0
0.0000%
$0.00
—
Pamela Esposito
Director
—
$4.07M (16) scheduled
−$4.07M
1,000
0.0012%
$116.12K
—
Noah Goodman
Chief Business Officer
—
$2.22M (9) scheduled
−$2.22M
47,179
0.0567%
$5.48M
+10,282%
Elena Ridloff
Director
—
$2.06M (7) scheduled
−$2.06M
0
0.0000%
$0.00
—
Jeffrey W. Albers
Director
—
$1.80M (8) scheduled
−$1.80M
0
0.0000%
$0.00
—
Brian Adams
Chief Legal Officer
—
$744.30K (3)
−$744.30K
50,254
0.0604%
$5.84M
—
Joanna Horobin
Director
—
$280.40K (2) scheduled
−$280.40K
0
0.0000%
$0.00
—
Ellen Chiniara
Chief Legal Officer
—
$273.30K (4)
−$273.30K
80,085
0.0963%
$9.30M
+3,914%
Elaine Caughey
Chief Business Officer
—
$22.13K (2)
−$22.13K
18,986
0.0228%
$2.20M
+786.0%
Steven Edward Hall
Director
—
—
—
2,192,249
2.64%
$254.56M
—
Redmile Group, LLC entity
10% owner
—
—
—
1,630,660
1.96%
$189.35M
—
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% owner
—
—
—
959,211
1.15%
$111.38M
—
Alexandria Venture Investments, LLC entity
10% owner
—
—
—
467,932
0.5628%
$54.34M
—
Terence Rooney
Chief Medical Officer
—
—
—
38,000
0.0457%
$4.41M
—